Tenax Therapeutics (NASDAQ:TENX) Earns Outperform Rating from Analysts at William Blair
William Blair assumed coverage on shares of Tenax Therapeutics (NASDAQ:TENX – Free Report) in a report released on Monday morning, MarketBeat Ratings reports. The brokerage issued an outperform rating on the specialty pharmaceutical company’s stock. William Blair also issued estimates for Tenax Therapeutics’ Q3 2024 earnings at ($1.50) EPS, Q4 2024 earnings at ($1.35) EPS, […]
More Stories
Saudi Arabia Reports Aramco’s Administrative Building on Fire After Being Struck
By Aldgra Fredly A fire broke out at an administrative building owned by Saudi Arabia’s state-owned oil giant after it...
Who is Lisa Bonet? Recent News, Early Life, Marriage, and More
Readers often look for clear details about Lisa Bonet, the famous actress best known for playing Denise Huxtable on the...
US Hits Bank of America With $1.2 Billion in Penalties for Security Violations
By Jill McLaughlin The U.S. Treasury fined Bank of America $1.21 billion for violations of anti-money laundering and sanctions laws,...
Tens of Thousands of People Double-Enrolled, Removed From Obamacare: Officials
By Zachary Stieber Health officials poring over death records and other data have found that 189,000 people were improperly enrolled...
Consumer Prices Rise 0.6 Percent, Lifting Annual Inflation Above Expectations
By Andrew Moran Consumers faced higher monthly cost pressures in September as surging gasoline prices resulted in hotter annual inflation,...
Is Lanterns Season 2 Renewed? Plot, Release Date, and Episodes
Television series by Chris Mundy: Lanterns update! Fans are excited to know the renewal status of the famous superhero series...